Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas
Pharma
BIO-WuXi, Takeda, FDA-Carvykti—Fierce Pharma Asia
WuXi AppTec left BIO amid alleged biosecurity concerns. Takeda will close a gene therapy plant. The FDA flagged early deaths in a Carvykti trial.
Angus Liu
Mar 15, 2024 10:15am
The top 10 drugs losing US exclusivity in 2024
Mar 11, 2024 3:00am
Apellis working through continued challenges with Syfovre launch
Feb 28, 2024 11:53am
Daiichi Sankyo, Astellas, Novartis and more—Fierce Pharma Asia
Feb 23, 2024 8:06am
Pfizer wins pharma ad Super Bowl, beating Astellas' Veozah spot
Feb 13, 2024 7:14am
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am